FDA Approves Journavx Drug to Treat Pain Without Addiction Risk
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
FDA Approves Journavx Drug to Treat Pain Without Addiction Risk The drug, Journavx by Vertex Pharmaceuticals, blocks pain signals to the brain, making it nonaddictive.
1 1.0k 0 01-31
6 1.1k 0 01-31
9 1.2k 0 01-31